Connection

Kwok-Yung Yuen to Databases, Pharmaceutical

Back to Details
This is a "connection" page, showing publications Kwok-Yung Yuen has written about Databases, Pharmaceutical.
Kwok-Yung Yuen
Connection Strength
0.173
Databases, Pharmaceutical
  1. Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system. Pharmacol Res. 2020 09; 159:104960.
    View in: PubMed
    Score: 0.173
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.